Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1,777,227
-
Shares change
-
-1,327,291
-
Total reported value, excl. options
-
$7,961,246
-
Value change
-
-$6,157,610
-
Put/Call ratio
-
1.23%
-
Number of buys
-
8
-
Number of sells
-
-29
-
Price
-
$4.48
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2018
47 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,777,227 shares
of 33,289,095 outstanding shares and own 5.34% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (790,875 shares), MILLENNIUM MANAGEMENT LLC (207,768 shares), GEODE CAPITAL MANAGEMENT, LLC (127,077 shares), Paloma Partners Management Co (89,025 shares), BlackRock Inc. (85,094 shares), ELEMENT CAPITAL MANAGEMENT LLC (73,526 shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (50,476 shares), NORTHERN TRUST CORP (44,893 shares), DIMENSIONAL FUND ADVISORS LP (37,610 shares), and LMR Partners LLP (34,326 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.